AVE1231

CAS No. 767334-89-4

AVE1231( —— )

Catalog No. M36265 CAS No. 767334-89-4

AVE1231 is a TASK-1 channel blocker that inhibits TASK-1 and can be used in the study of atrial fibrillation.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 372 In Stock
10MG 508 In Stock
25MG 770 In Stock
50MG 1014 In Stock
100MG 1367 In Stock
200MG 1841 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    AVE1231
  • Note
    Research use only, not for human use.
  • Brief Description
    AVE1231 is a TASK-1 channel blocker that inhibits TASK-1 and can be used in the study of atrial fibrillation.
  • Description
    AVE1231 is a TASK-1 channel blocker that inhibits TASK-1 and can be used in the study of atrial fibrillation.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Potassium Channel
  • Recptor
    Potassium Channel
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    767334-89-4
  • Formula Weight
    405.51
  • Molecular Formula
    C20H27N3O4S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N(S(CCCC)(=O)=O)C1=C(C(N[C@H](CC)C=2C=CC(OC)=NC2)=O)C=CC=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Glibornuride

    Glibornuride is a blocker of ATP-sensitive K+ channel(pKi: 5.75). Glibornuride inhibits high affinity [3H]-glibenclamide binding with the potencies expected from their K+ channel activity.

  • XE 991 dihydrochlori...

    A potent, selective and orally active blocker of voltage-gated potassium channels Kv7 (KCNQ) that blocks KCNQ1, KCNQ2 and KCNQ2+KCNQ3 with Kd of 0.78, 0.7 and 0.6 uM, respectively.

  • Tolazamide

    Tolazamide is an oral blood glucose lowering drug used for people with Type 2 diabetes.